Results 71 to 80 of about 956 (195)

Dietary n-3 Fatty Acids Increase Spleen Size and Postendotoxin Circulating TNF in Mice; Role of Macrophages, Macrophage Precursors, and Colony-Stimulating Factor-1

open access: yes, 1996
In experimental studies in mice, dietary supplementation with n-3 fatty acids (FA) alleviates inflammation and increases resistance to infection. Nevertheless, TNF production capacity was found to be increased in n-3 FA-fed mice.
Buurman, Wim A.   +7 more
core   +1 more source

Biphosphonates-related osteonecrosis of the jaw: multicenter study

open access: yes, 2012
Biphosphonates-related osteonecrosis of the jaw is defined as an exposure of necrotic bone in maxillofacial region,which persists more than 8 weeks in patients treated or,in course of treatment whit biphosphonate, not been subjected to radiation therapy ...
GARAU, VALENTINO   +8 more
core  

Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate

open access: yesDrug Design, Development and Therapy, 2013
Ying-Chen Chen,1,* Hsiu-O Ho,1,* Chiao-Chi Chiu,1 Ming-Thau Sheu1,2 1School of Pharmacy, College of Pharmacy, Taipei Medical University, 2Clinical Research Center and Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei,
Chen YC, Ho HO, Chiu CC, Sheu MT
doaj  

Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid

open access: yes, 2010
The molecular triad, which includes the receptor activator of nuclear factor kappa-B ligand (RANKL), its receptor RANK, and the endogenous soluble RANKL decoy receptor osteoprotegerin (OPG), has emerged as an important determinant of bone metabolism.
Mountzios, Giannis   +15 more
core  

Biphosphonate-Related Osteonecrosis (BRONJ) in Cancer Patients: Retrospective Study

open access: yes, 2018
GİRİŞ ve AMAÇ: Bisfosfonatlar genellikle menapoz sonrası, kortikosteroidin artırdığı osteoporoz, Paget hastalığı, malinite ve osteolizis ile ilişkili hiperkalsemi ve metastatik kemik hastalıkları tedavisinde kullanılır. Bifosfonata bağlı osteonekroz çene
Candan Efeoğlu   +3 more
core   +2 more sources

Diffuse skeletal pain after administration of alendronate

open access: yes, 2010
Background : Osteoporosis is caused by bone resorption in excess of bone formation, and bisphosphonates, are used to inhibit bone resorption.
Ozaras, Nihal, Rezvani, Aylin
core   +2 more sources

Concurrent Osteonecrosis of the Jaw and Hip in a Child With Severe Aplastic Anemia Undergoing Transplant

open access: yes
We present the first case of concomitant hip and jaw osteonecrosis in a 10-year-old child with aplastic anemia undergoing a transplant. Biphosphonate treatment may be beneficial for hip osteonecrosis but harmful for jaw osteonecrosis.
TOPUZ TÜRKCAN, BÜŞRA   +5 more
core   +1 more source

Mice are protected from lytic bone lesions using bisphosphonates and osteoprotegerin (m OPG).

open access: yes, 2015
A) Representative CT Scan images of skulls of MuTuDC injected mice (subcutaneously on the calvaria, close to the left parietal bone). Mice were treated with either PBS (control) or the biphosphonate Aclasta B) Representative stereomicroscopic images of ...
Paolo Vezzoni (70525)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy